查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991425

全球血小板濃縮血漿（PRP）市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Platelet Rich Plasma Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計血小板濃縮血漿 (PRP) 市場將從 2025 年的 9.3 億美元成長到 2034 年的 22 億美元，2026 年至 2034 年的複合年成長率為 9.99%。

由於人們對再生醫學和微創療法的興趣日益濃厚，全球富血小板血漿（PRP）市場正經歷顯著成長。 PRP提取自患者自身的血液，富含促進組織癒合和再生的濃縮生長因子。它廣泛應用於整形外科治療、美容手術和運動醫學。人們對天然、非手術治療方法的需求不斷成長，也推動了該市場的快速擴張。

推動該市場成長的因素有很多，包括運動傷害和肌肉骨骼疾病發生率的上升。醫療專業人員擴大採用濃縮血小板血漿療法來加速癒合和縮短恢復時間。該療法也被應用於美容行業，用於活膚和頭髮生長治療。製備技術的進步和臨床通訊協定的改進進一步提高了濃縮血小板血漿療法的可靠性和普及性。

隨著研究不斷拓展富血小板血漿的醫療應用，預計市場將持續成長。整形外科、牙科和皮膚科等領域的新療法有望創造更多機會。患者和醫療專業人員對再生醫學認知的提高也將進一步推動市場需求。隨著醫療趨勢向個人化醫療和生物療法轉變，富血小板血漿有望繼續保持其作為重要治療選擇的地位。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球血小板濃縮血漿（PRP）市場：以血小板濃縮血漿（PRP）類型分類

  • 市場分析、洞察與預測
  • 純血小板濃縮血漿（P-PRP）
  • 富白血球/血小板血漿（L-PRP）
  • 純血小板濃縮纖維蛋白（P-PRF）
  • 白血球-血小板濃縮纖維蛋白（L-PRF）

第5章 全球血小板濃縮血漿（PRP）市場：依來源分類

  • 市場分析、洞察與預測
  • 自體血小板血漿
  • PRP來自同一物種

第6章 全球血小板濃縮血漿（PRP）市場：依應用分類

  • 市場分析、洞察與預測
  • 整形外科
  • 運動醫學
  • 皮膚科/創傷治療
  • 整形手術
  • 眼科手術
  • 神經外科
  • 心臟外科手術
  • 一般外科
  • 其他

第7章 全球血小板濃縮血漿（PRP）市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院及門診手術中心
  • 皮膚科和美容診所
  • 牙醫診所
  • 運動診所和復健中心
  • 其他

第8章 全球血小板濃縮血漿（PRP）市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Johnson & Johnson Services Inc
    • Stryker
    • Zimmer Biomet
    • Arthrex Inc
    • Terumo BCT Inc
    • Crown Aesthetics
    • Celling Biosciences
    • EmCyte Corporation
    • Juventix Regenerative Medical LLC
    • APEX Biologix
    • Dr PRP USA LLC
    • Changsha Yingtai Instrument Co. Ltd
    • Accuquik Test Kits
    • Aspire Medical Innovation
    • Factor Medical Inc
簡介目錄
Product Code: VMR11213862

The Platelet Rich Plasma Market size is expected to reach USD 2.20 Billion in 2034 from USD 0.93 Billion (2025) growing at a CAGR of 9.99% during 2026-2034.

The global platelet rich plasma market has experienced significant growth due to increasing interest in regenerative medicine and minimally invasive therapies. Platelet rich plasma is derived from a patient's own blood and contains concentrated growth factors that promote tissue healing and regeneration. It is widely used in orthopedic treatments, cosmetic procedures, and sports medicine. The growing demand for natural and non-surgical treatment options has contributed to the market's rapid expansion.

Several factors are driving the growth of this market, including the rising incidence of sports injuries and musculoskeletal disorders. Healthcare professionals increasingly use platelet rich plasma therapy to accelerate healing and reduce recovery time. In the cosmetic industry, it is also used for skin rejuvenation and hair restoration treatments. Advancements in preparation technologies and improved clinical protocols have further increased the reliability and adoption of platelet rich plasma therapies.

The market is expected to continue growing as research expands the range of medical applications for platelet rich plasma. New treatment approaches in orthopedics, dentistry, and dermatology may create additional opportunities. Increasing awareness among patients and healthcare providers about regenerative therapies will likely drive further demand. As healthcare trends move toward personalized and biologically based treatments, platelet rich plasma is expected to remain an important therapeutic option.

MARKET SEGMENTATION

By Type of Platelet-Rich Plasma (PRP)

  • Pure Platelet-Rich Plasma (P-PRP)
  • Leukocyte-and Platelet-Rich Plasma (L-PRP)
  • Pure Platelet-Rich Fibrin (P-PRF)
  • Leukocyte- and Platelet-Rich Fibrin (L-PRF)

By Source

  • Autologous PRP
  • Allogenic PRP

By Application

  • Orthopedics
  • Sports Medicine
  • Dermatology / Wound Healing
  • Cosmetic Surgery
  • Ophthalmic Surgery
  • Neurosurgery
  • Cardiac Surgery
  • General Surgery
  • Others

By End-user

  • Hospitals and Ambulatory Surgical Centers
  • Dermatology and Aesthetic Clinics
  • Dental Clinics
  • Sport Clinics and Rehabilitation Centers
  • Others

COMPANIES PROFILED

  • Johnson Johnson Services Inc, Stryker, Zimmer Biomet, Arthrex Inc, Terumo BCT Inc, Crown Aesthetics, Celling Biosciences, EmCyte Corporation, Juventix Regenerative Medical LLC, APEX Biologix, Dr PRP USA LLC, Changsha Yingtai Instrument Co Ltd, Accuquik Test Kits, Aspire Medical Innovation, Factor Medical Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PLATELET RICH PLASMA MARKET: BY TYPE OF PLATELET-RICH PLASMA (PRP) 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type Of Platelet-rich Plasma (prp)
  • 4.2. Pure Platelet-Rich Plasma (P-PRP) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Leukocyte-and Platelet-Rich Plasma (L-PRP) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Pure Platelet-Rich Fibrin (P-PRF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Leukocyte- and Platelet-Rich Fibrin (L-PRF) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PLATELET RICH PLASMA MARKET: BY SOURCE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Source
  • 5.2. Autologous PRP Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Allogenic PRP Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PLATELET RICH PLASMA MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Orthopedics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Sports Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Dermatology / Wound Healing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cosmetic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Ophthalmic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.8. Cardiac Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.9. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PLATELET RICH PLASMA MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals and Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Dermatology and Aesthetic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Dental Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Sport Clinics and Rehabilitation Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PLATELET RICH PLASMA MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Type Of Platelet-rich Plasma (prp)
    • 8.2.2 By Source
    • 8.2.3 By Application
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Type Of Platelet-rich Plasma (prp)
    • 8.3.2 By Source
    • 8.3.3 By Application
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Type Of Platelet-rich Plasma (prp)
    • 8.4.2 By Source
    • 8.4.3 By Application
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Type Of Platelet-rich Plasma (prp)
    • 8.5.2 By Source
    • 8.5.3 By Application
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Type Of Platelet-rich Plasma (prp)
    • 8.6.2 By Source
    • 8.6.3 By Application
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PLATELET RICH PLASMA INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Johnson & Johnson Services Inc
    • 10.2.2 Stryker
    • 10.2.3 Zimmer Biomet
    • 10.2.4 Arthrex Inc
    • 10.2.5 Terumo BCT Inc
    • 10.2.6 Crown Aesthetics
    • 10.2.7 Celling Biosciences
    • 10.2.8 EmCyte Corporation
    • 10.2.9 Juventix Regenerative Medical LLC
    • 10.2.10 APEX Biologix
    • 10.2.11 Dr PRP USA LLC
    • 10.2.12 Changsha Yingtai Instrument Co. Ltd
    • 10.2.13 Accuquik Test Kits
    • 10.2.14 Aspire Medical Innovation
    • 10.2.15 Factor Medical Inc